William Mack & Associates
CLX icon

William Mack & Associates’s Clorox CLX Stock Holding History

William Mack & Associates’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.48K Buy
+105
New +$10.1K ﹤0.01% 426

Other funds holding CLX

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
VanEck Associates
VanEck Associates New York $165B AUM 72.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Beutel, Goodman & Co
Beutel, Goodman & Co Toronto, Ontario, Canada $12.7B AUM 12.76% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

William Mack & Associates's CLX Position: Q3 2026 in Review

William Mack & Associates opened a new position in Clorox (CLX) in Q3 2026: 105 shares worth $8.48K. The stake represents ﹤0.01% of the portfolio and ranks #426 among its holdings.

832 funds tracked by Wall St. Rank hold CLX as of Q3 2026.

  • William Mack & Associates held 105 shares of Clorox worth $8.48K as of Q3 2026.
  • Clorox was a new William Mack & Associates position in Q3 2026.
  • Clorox made up ﹤0.01% of William Mack & Associates's portfolio in Q3 2026, its #426 holding.
  • 832 funds tracked by Wall St. Rank held Clorox as of Q3 2026.

Based on William Mack & Associates's 13F filing for Q3 2026, filed 27 Oct 2026.